Prednisone and Aspirin in Women with Autoantibodies and Unexplained Recurrent Fetal Loss
Open Access
- 17 July 1997
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 337 (3) , 148-154
- https://doi.org/10.1056/nejm199707173370302
Abstract
Recurrent fetal loss has been well described in women with antiphospholipid antibodies. Such women also often have other autoantibodies commonly found in patients with systemic lupus erythematosus. Treating them with prednisone and aspirin may reduce the risk of fetal loss.Keywords
This publication has 22 references indexed in Scilit:
- CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant womenThe Lancet, 1994
- Prevention of Preeclampsia with Low-Dose Aspirin in Healthy, Nulliparous Pregnant WomenNew England Journal of Medicine, 1993
- Prevention of Miscarriage in Antiphospholipid SyndromeAutoimmunity, 1992
- Autoantibodies in alcoholic liver diseaseThe American Journal of Medicine, 1990
- Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody testArchives of internal medicine (1960), 1986
- Pregnancy and AutoimmunityActa Haematologica, 1986
- Antibody to Cardiolipin as a Predictor of Fetal Distress or Death in Pregnant Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1985
- FETAL SURVIVAL AFTER PREDNISONE SUPPRESSION OF MATERNAL LUPUS-ANTICOAGULANTThe Lancet, 1983
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Cortisone in Disseminated Lupus Erythematosus During PregnancyObstetrics & Gynecology, 1955